Centaurus Financial, Inc. Astrazeneca PLC Transaction History

Centaurus Financial, Inc.

$1.44 Billion
Q3 2024

A detailed history of Centaurus Financial, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Centaurus Financial, Inc. holds 4,037 shares of AZN stock, worth $304,874. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,037

Previous 2,337 72.74%

Holding current value

$304,874

Previous $182,000 72.53%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$76.67 - $87.62 $130,339 - $148,954	1,700 Added 72.74%	4,037 $314,000
Q2 2024 Sep 20, 2024	BUY	$66.81 - $80.83 $156,134 - $188,899	2,337 New	2,337 $182,000
Q1 2023 May 17, 2023	SELL	$63.15 - $71.6 $378 - $429	-6 Reduced 0.29%	2,056 $143,000
Q4 2022 Feb 10, 2023	SELL	$54.21 - $70.44 $2,331 - $3,028	-43 Reduced 2.04%	2,062 $139,000
Q3 2022 Dec 05, 2022	SELL	$53.02 - $135.75 $51,482 - $131,813	-971 Reduced 31.57%	2,105 $115,000
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $24,059 - $28,882	-406 Reduced 11.66%	3,076 $203,000
Q1 2022 May 13, 2022	SELL	$55.72 - $67.12 $168,274 - $202,702	-3,020 Reduced 46.45%	3,482 $231,000
Q4 2021 Feb 01, 2022	SELL	$54.02 - $63.83 $25,389 - $30,000	-470 Reduced 6.74%	6,502 $379,000
Q3 2021 Nov 12, 2021	SELL	$55.56 - $60.79 $20,168 - $22,066	-363 Reduced 4.95%	6,972 $419,000
Q2 2021 Aug 10, 2021	SELL	$48.42 - $60.18 $60,525 - $75,225	-1,250 Reduced 14.56%	7,335 $439,000
Q1 2021 Apr 30, 2021	SELL	$47.16 - $54.44 $370,724 - $427,952	-7,861 Reduced 47.8%	8,585 $427,000
Q4 2020 Jan 25, 2021	BUY	$48.52 - $58.02 $65,599 - $78,443	1,352 Added 8.96%	16,446 $822,000
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $572,200 - $658,780	10,782 Added 250.05%	15,094 $827,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $185,847 - $238,496	4,312 New	4,312 $228,000
Q3 2018 Nov 05, 2018	SELL	$34.76 - $39.72 $275,333 - $314,622	-7,921 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$34.55 - $37.05 $273,670 - $293,473	7,921 New	7,921 $278,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centaurus Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Centaurus Financial, Inc. with notifications on news.

Account

Centaurus Financial, Inc. Astrazeneca PLC Transaction History